Probiotics can affect metabolic syndrome, type 2 diabetes mellitus, and obesity by regulating intestinal microbiota, favoring insulin signaling, and decreasing cholesterol levels. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.